BioCentury
ARTICLE | Company News

Chiron, Prizm deal

June 9, 1997 7:00 AM UTC

Prizm and CHIR's Chiron Technologies Center for Gene Therapy (San Diego, Calif.) will develop a gene therapy approach to cancer and other diseases. The agreement is for a feasibility study with defined milestones, and is expected to last six months, at which time the companies will decide terms and direction of further development. ...